Related Experiment Video
Updated: Mar 26, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Recent Progress in Therapeutic Strategies for Ischemic Stroke
1Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Abstract:
Possible strategies for treating stroke include neuroprotection in the acute phase of cerebral ischemia and stem cell therapy in the chronic phase of cerebral ischemia. Previously, we have studied the temporal and spatial expression patterns of c-fos, hypoxia inducible factor-1α (HIF-1α), heat shock protein 70 (HSP70), and annexin V after 90 min of transient middle cerebral occlusion in rats and concluded that there is a time window for neuroprotection from 12 to 48 h after ischemia. In addition, we have estimated the neuroprotective effect of glial cell line-derived neurotrophic factor (GDNF) by injecting Sendai viral vector containing the GDNF gene into the postischemic brain. This Sendai virus-mediated gene transfer of GDNF showed a significant neuroprotective effect in the ischemic brain. Additionally, we have administered GDNF and hepatocyte growth factor (HGF) protein into the postischemic rat brain and estimated the infarct size and antiapoptotic and antiautophagic effects. GDNF and HGF significantly reduced infarct size, the number of microtubule-associated protein 1 light chain 3 (LC3)-positive cells, and the number of terminal deoxynucleotidyl transferase-mediated dUTP-biotin in situ nick-end labeling (TUNEL)-positive cells, indicating that GDNF and HGF were greatly associated with not only the antiapoptotic effect but also the antiautophagic effects. Finally, we have previously transplanted undifferentiated iPSCs into the ipsilateral striatum and cortex at 24 h after cerebral ischemia. Histological analysis was performed at 14 and 28 days after cell transplantation, and we found that iPSCs could supply a great number of doublecortin-positive neuroblasts but also formed tridermal teratoma in the ischemic brain. Our results suggest that iPSCs have a potential to provide neural cells after ischemic brain injury if tumorigenesis is properly controlled. In the future, we will combine these strategies to develop more effective therapies for the treatment of strokes.
Insights
This study explored neuroprotection and stem cell therapy for stroke treatment. Combining glial cell line-derived neurotrophic factor (GDNF) and induced pluripotent stem cells (iPSCs) shows promise for stroke recovery, pending control of iPSC-related tumor formation.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Stroke Research
Background:
- Stroke treatment strategies include acute neuroprotection and chronic stem cell therapy.
- Previous research identified a neuroprotection window (12-48h) post-ischemia.
- Investigated temporal and spatial expression of key proteins (c-fos, HIF-1α, HSP70, annexin V) after transient middle cerebral artery occlusion in rats.
Purpose of the Study:
- To evaluate the neuroprotective effects of glial cell line-derived neurotrophic factor (GDNF) and hepatocyte growth factor (HGF) in ischemic stroke models.
- To assess the potential of induced pluripotent stem cells (iPSCs) for neural regeneration after stroke.
- To explore combined therapeutic strategies for stroke treatment.
Main Methods:
- Administered GDNF via Sendai viral vector gene transfer into post-ischemic rat brains.
- Administered GDNF and HGF proteins into post-ischemic rat brains.
- Transplanted undifferentiated iPSCs into the ischemic striatum and cortex of rats.
Main Results:
- Sendai virus-mediated GDNF gene transfer demonstrated significant neuroprotection.
- GDNF and HGF reduced infarct size, apoptosis (TUNEL-positive cells), and autophagy (LC3-positive cells).
- iPSC transplantation yielded doublecortin-positive neuroblasts but also resulted in teratoma formation.
Conclusions:
- GDNF and HGF exhibit both anti-apoptotic and anti-autophagic effects, reducing stroke-induced damage.
- iPSCs hold potential for neural cell replacement after ischemic brain injury, provided tumorigenesis is managed.
- Combining neurotrophic factor therapy with stem cell transplantation may offer a more effective stroke treatment approach.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management

